We will be happy to assist
CONTACT US TO
FIND OUT MORE
For research collaboration inquiries or platform information please contact our team using the form below.
Get in touch with our team!
We use your information only to respond to your inquiry.
FAQ
Most frequent questions and answers
AXON Dx products are designed to support research and translational investigations in: Circulating tumor cell studies, Rare-cell enumeration, Oncology biomarker research, Assay feasibility and validation studies, Academic and industry collaborations
CTCs provide insight into tumor behavior and disease progression, allowing researchers to study cancer biology using a minimally invasive sample.
No. AXON Dx develops diagnostic tools and research technologies but does not offer clinical testing services to patients.
CTCs are extremely rare—often only 1–10 cells per milliliter of whole blood—requiring highly sensitive analytical methods to identify them among millions of nucleated blood cells.
AXON Dx is headquartered in Virginia, USA.